NEW YORK (GenomeWeb) – Biocartis announced today that it is developing a blood-based Ebola test in collaboration with Janssen Diagnostics and the Institute for Tropical Medicine in Antwerp.

The Rapid Ebola Virus Triage Test is being designed to run on Biocartis' Idylla real-time PCR-based molecular diagnostics system, which is already CE-IVD marked in Europe. The platform takes approximately 90 minutes to analyze a blood sample and can be operated in both laboratory and field settings, according to the company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.